BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33406492)

  • 1. Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
    Gupta M; Sherrow C; Krone ME; Blais EM; Pishvaian MJ; Petricoin EF; Matrisian LM; DeArbeloa P; Gregory G; Brown A; Zalewski O; Prinzing G; Roche C; Kanehira K; Mukherjee S; Iyer R; Fountzilas C
    J Natl Compr Canc Netw; 2021 Jan; 19(1):10-15. PubMed ID: 33406492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion.
    O'Reilly EM; Hechtman JF
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii36-viii40. PubMed ID: 31605106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report.
    Xu H; Wang X; Zhou S; Hu Q; Cao D
    Tumori; 2021 Dec; 107(6):NP24-NP27. PubMed ID: 33345750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
    Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
    Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors.
    Al-Hader A; Al-Rohil RN; Han H; Von Hoff D
    World J Gastroenterol; 2017 Dec; 23(45):7945-7951. PubMed ID: 29259370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
    J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
    Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
    J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report.
    Ohara Y; Oda T; Enomoto T; Hisakura K; Akashi Y; Ogawa K; Owada Y; Domoto Y; Miyazaki Y; Shimomura O; Kurata M; Ohkohchi N
    World J Surg Oncol; 2018 Aug; 16(1):158. PubMed ID: 30075727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterisation of pancreatic ductal adenocarcinoma with
    Allen MJ; Zhang A; Bavi P; Kim JC; Jang GH; Kelly D; Perera S; Denroche RE; Notta F; Wilson JM; Dodd A; Ramotar S; Hutchinson S; Fischer SE; Grant RC; Gallinger S; Knox JJ; O'Kane GM
    J Clin Pathol; 2023 Mar; 76(3):158-165. PubMed ID: 34583947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
    Sun T; Gilani S; Jain D; Cai G
    Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.
    Lee CL; Holter S; Borgida A; Dodd A; Ramotar S; Grant R; Wasson K; Elimova E; Jang RW; Moore M; Kim TK; Khalili K; Moulton CA; Gallinger S; O'Kane GM; Knox JJ
    World J Gastroenterol; 2022 Dec; 28(45):6421-6432. PubMed ID: 36533108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NTRK Fusions: A new way of treatment for gastro-intestinal tumor?].
    Ouali K; Pellat A; Cohen R; Svrcek M; Penault-Llorca F; André T
    Bull Cancer; 2020 Apr; 107(4):447-457. PubMed ID: 32067719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
    Seo S; Yoo C; Kim KP; Ryoo BY; Chang HM; Hong SM; Lee JH; Song KB; Hwang DW; Kim KH; Hwang S; Kim SC
    J Dig Dis; 2017 Aug; 18(8):480-486. PubMed ID: 28671770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature.
    Antoine M; Khitrik-Palchuk M; Saif MW
    JOP; 2007 Nov; 8(6):783-9. PubMed ID: 17993731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case report.
    Zhang L; Liu H; Tian Y; Wang H; Yang X
    BMC Pulm Med; 2021 Apr; 21(1):125. PubMed ID: 33865348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report.
    Ardalan B; Azqueta JI; England J; Eatz TA
    Cold Spring Harb Mol Case Stud; 2021 Oct; 7(5):. PubMed ID: 34667063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan.
    Sakakida T; Ishikawa T; Doi T; Morita R; Kataoka S; Miyake H; Yamaguchi K; Moriguchi M; Sogame Y; Yasuda H; Iwasaku M; Konishi H; Takayama K; Itoh Y
    J Gastroenterol; 2023 Jun; 58(6):575-585. PubMed ID: 37029223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib.
    Caldwell KJ; De La Cuesta E; Morin C; Pappo A; Helmig S
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28330. PubMed ID: 32452122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.